How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety / Perrone, S; Massaro, F; Alimena, G; Breccia, M. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - 17:11(2016), pp. 1517-1526. [10.1080/14656566.2016.1190335]
How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety
Breccia M
2016
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.